COST-EFFECTIVENESS OF ANTIVIRAL PROPHYLAXIS DURING PREGNANCY TO PREVENT PERINATAL HEPATITIS B INFECTION IN SOUTH KOREA

Author(s)

Lee D¹, Park SM², Shin HY³
¹Seoul National University Hospital, Seoul, Korea, Republic of (South), ²Seoul National University, Seoul, Korea, Republic of (South), ³Myongji Hospital, Seonam University, Goyang, Korea, Republic of (South)

Presentation Documents

PIN32--strong-u-lee-d-u-sup-1-sup-strong-park-sm-sup-2-sup-shin-hy-sup-3-sup-br-sup-1-sup-seoul-national-university-hospital-seoul-korea-republic-of-south-sup-2-sup-seoul-national-university-seoul-korea-republic-of-south-sup-3-sup-myongji-h ...

OBJECTIVES: To analyze the cost-effectiveness of the nationwide Perinatal Hepatitis B Prevention Program (PHBPP) and identify the optimal strategy of eliminating mother-to-child transmission of hepatitis B virus (HBV) in Korea

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PIN32

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic

Economic Evaluation

Presentation